BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36401646)

  • 1. The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans.
    Nottage JF; Gabay A; De Meyer K; Herrik KF; Bastlund JF; Christensen SR; Gijsen S; Mehta MA
    Psychopharmacology (Berl); 2023 Jan; 240(1):59-75. PubMed ID: 36401646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRX-101, a Rapid-Acting Anti-Depressant, Does Not Cause Neurotoxicity Following Ketamine Administration in Preclinical Models.
    Jordan W; Sapko MT; Siegel R; Javitt J
    Int J Toxicol; 2023; 42(5):379-385. PubMed ID: 37226048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.
    Chen MH; Cheng CM; Gueorguieva R; Lin WC; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Krystal JH; Su TP
    Neuropsychopharmacology; 2019 Nov; 44(12):2112-2118. PubMed ID: 31421635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-cycloserine is not susceptible to self-administration using an intravenous self-administration model in male ketamine-habituated Sprague-Dawley rats.
    Sapko MT; Hanania T; Chang Q; Javitt JC
    Pharmacol Biochem Behav; 2023 Jun; 227-228():173586. PubMed ID: 37330114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers.
    van Berckel BN; Lipsch C; Gispen-de Wied C; Wynne HJ; Blankenstein MA; van Ree JM; Kahn RS
    Psychopharmacology (Berl); 1998 Jul; 138(2):190-7. PubMed ID: 9718289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
    Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
    Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite Modulation of the NMDA Receptor by Glycine and S-Ketamine and the Effects on Resting State EEG Gamma Activity: New Insights into the Glutamate Hypothesis of Schizophrenia.
    Haaf M; Curic S; Rauh J; Steinmann S; Mulert C; Leicht G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence.
    Krystal JH; Petrakis IL; Limoncelli D; Nappi SK; Trevisan L; Pittman B; D'Souza DC; Suckow RF
    Neuropsychopharmacology; 2011 Feb; 36(3):701-10. PubMed ID: 21124304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the NMDA receptor partial agonist, d-cycloserine, on emotional processing and autobiographical memory.
    Chen R; Capitão LP; Cowen PJ; Harmer CJ
    Psychol Med; 2021 Nov; 51(15):2657-2665. PubMed ID: 32375905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
    Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
    Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings.
    Rivolta D; Heidegger T; Scheller B; Sauer A; Schaum M; Birkner K; Singer W; Wibral M; Uhlhaas PJ
    Schizophr Bull; 2015 Sep; 41(5):1105-14. PubMed ID: 25987642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
    Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
    Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NMDA receptor antagonists and antipsychotics on high frequency oscillations recorded in the nucleus accumbens of freely moving mice.
    Hunt MJ; Olszewski M; Piasecka J; Whittington MA; Kasicki S
    Psychopharmacology (Berl); 2015 Dec; 232(24):4525-35. PubMed ID: 26446869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-methyl-D-aspartate receptor ligands on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting procedure.
    Yates JR; Gunkel BT; Rogers KK; Hughes MN; Prior NA
    Psychopharmacology (Berl); 2017 Feb; 234(3):461-473. PubMed ID: 27837332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.
    Heresco-Levy U; Javitt DC; Gelfin Y; Gorelik E; Bar M; Blanaru M; Kremer I
    J Affect Disord; 2006 Jul; 93(1-3):239-43. PubMed ID: 16677714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine.
    Sheinin A; Shavit S; Benveniste M
    Neuropharmacology; 2001 Aug; 41(2):151-8. PubMed ID: 11489451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining D-cycloserine with appetitive extinction learning modulates amygdala activity during recall.
    Ebrahimi C; Koch SP; Friedel E; Crespo I; Fydrich T; Ströhle A; Heinz A; Schlagenhauf F
    Neurobiol Learn Mem; 2017 Jul; 142(Pt B):209-217. PubMed ID: 28512009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The olfactory bulb is a source of high-frequency oscillations (130-180 Hz) associated with a subanesthetic dose of ketamine in rodents.
    Hunt MJ; Adams NE; Średniawa W; Wójcik DK; Simon A; Kasicki S; Whittington MA
    Neuropsychopharmacology; 2019 Jan; 44(2):435-442. PubMed ID: 30140046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users.
    Shram MJ; Henningfield JE; Apseloff G; Gorodetzky CW; De Martin S; Vocci FL; Sapienza FL; Kosten TR; Huston J; Buchhalter A; Ashworth J; Lanier R; Folli F; Mattarei A; Guidetti C; Comai S; O'Gorman C; Traversa S; Inturrisi CE; Manfredi PL; Pappagallo M
    Transl Psychiatry; 2023 Jun; 13(1):192. PubMed ID: 37286536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on sexual memory consolidation in women.
    Both S; Van Veen RJB; Brom M; Weijenborg PTM
    Psychopharmacology (Berl); 2020 May; 237(5):1291-1303. PubMed ID: 31984445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.